RhumbLine Advisers’s Eton Pharmaceutcials ETON Stock Holding History

RhumbLine Advisers’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	33,703 +2,977	+10%	+$87.3K	﹤0.01%	2191
2026 Q1	$758K	Buy	30,726 +290	+1%	+$5.07K	﹤0.01%	2352
2025 Q4	$515K	Sell	30,436 -5,688	-16%	-$100K	﹤0.01%	2646
2025 Q3	$785K	Sell	36,124 -470	-1%	-$7.8K	﹤0.01%	2391
2025 Q2	$521K	Buy	+36,594	New	+$578K	﹤0.01%	2659
2021 Q2	–	Sell	-10,340	Closed	-$76K	–	3026
2021 Q1	$76K	Hold	10,340	–	–	﹤0.01%	2958
2020 Q4	$84K	Buy	+10,340	New	+$79.8K	﹤0.01%	2984
2020 Q3	–	Sell	-11,630	Closed	-$63K	–	2993
2020 Q2	$63K	Buy	+11,630	New	+$57.8K	﹤0.01%	3015

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

RhumbLine Advisers's ETON Position: Q2 2026 in Review

RhumbLine Advisers increased its Eton Pharmaceutcials (ETON) stake by 9.7% in Q2 2026, buying an estimated $87.3K and bringing the position to 33,703 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

RhumbLine Advisers first reported a position in ETON in Q2 2020 and has held it in 8 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

RhumbLine Advisers held 33,703 shares of Eton Pharmaceutcials worth $1.22M as of Q2 2026.
RhumbLine Advisers bought 2,977 Eton Pharmaceutcials shares in Q2 2026, an estimated $87.3K.
Eton Pharmaceutcials made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2191 holding.
RhumbLine Advisers first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 8 quarters since.
164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.